摘要:
A method of evaluating the degree of cancerization of a specimen originating in a mammal characterized by comprising: (1) the first step of measuring the methylation frequency or an indication correlating thereto in Fibrillin 2 gene contained in the mammal-origin specimen; and (2) the second step of judging the degree of cancerization of the above-described specimen based on the difference obtained by comparing the methylation frequency or the indication correlating thereto having been measured above with the data of a control; and so on.
摘要:
The present invention relates to a method of concentrating low molecular weight peptides in the supernatant of serum-free cultured cells, said method comprising allowing the peptides to bind to a strong cation exchanger under an acid condition, and eluting them under an alkali condition to concentrate the peptide. Furthermore, peptides having the amino acid sequence as set forth in SEQ ID NO: 1 or 2, and a method of screening cancer markers using antibody to these peptides, are disclosed.
摘要翻译:本发明涉及一种在无血清培养细胞的上清液中浓缩低分子量肽的方法,所述方法包括使肽在酸性条件下与强阳离子交换剂结合,并在碱性条件下洗脱以浓缩 肽。 此外,公开了具有SEQ ID NO:1或2所示的氨基酸序列的肽以及使用这些肽的抗体筛选癌症标记物的方法。
摘要:
The present invention has for its subject to obtain a composition for preventing cancer efficient for preventing cancer or preventing cancer recurred after its therapy, or to obtain a pharmaceutical product, food and drink, and cosmetic having a function for preventing cancer. The present inventors found that a composition containing coenzyme Q has a cancer-preventive effect.
摘要:
A new method for treating cancer by inducing apoptosis exclusively in cancer cells and killing them is provided. The present invention relates to a transcriptional factor, comprising p53 or a mutated type p53, wherein one or more amino acids are deleted, substituted or added with respect to the amino sequence of p53, and clathrin heavy chains and having an activity to induce apoptosis of cancer cells. The transcriptional factor enhances the transcriptional activity of p53AIP1 promoter and induces apoptosis of cancer cells.
摘要:
The inventors clarified the enzyme phosphorylating the serine residue at amino acid position 46 of tumor suppressor protein p53 and further elucidated the mechanism in regulation of inducibility of apoptosis by p53. As the results, the inventors provide a completely new enzyme comprising casein kinase 2 and p53DINP1
摘要:
By analyzing hematopoietic stem cell proliferation regulators produced by stroma cells, a cDNA library is constructed and novel hematopoiesis-associated genes are isolated. Genes encoding the proteins as specified in the following (a) or (b): (a) having an amino acid sequence represented by one of SEQ ID NOS selected from the group consisting of SEQ ID NOS: 2, 4, 6, 8, 10 and 12; or (b) having an amino acid sequence derived from the amino acid sequence as defined in the above (a) by deletion, substitution or addition of one to several amino acids andhaving an activity of regulation hematopoietic stem cell proliferation.
摘要翻译:通过分析由间质细胞产生的造血干细胞增殖调节因子,构建cDNA文库,分离出新的造血相关基因。 编码如以下(a)或(b)中所指定的蛋白质的基因:(a)具有由选自SEQ ID NO:2,4,6,8或8的SEQ ID NOS之一表示的氨基酸序列, 10和12; 或(b)通过缺失,取代或添加一至数个氨基酸并具有调节造血干细胞增殖活性的方式具有源自上述(a)所定义的氨基酸序列的氨基酸序列。
摘要:
The present invention provides a polypeptide represented by the following amino acid sequence: wherein n is 0 or 1 and X represents or a fragment thereof (n = 0: SEQ ID NO:1, n = 1: SEQ ID NO:2), a recombinant DNA coding for the polypeptide, a vector containing the recombinant DNA, the preparation of a transformant carrying the vector, and the production of the polypeptide with the transformant. The invention also provides a method for promoting an increase in the number of platelets in a mammal using a polypeptide having a heparin binding secretory transforming factor 2 (hst-2) activity. The polypeptide can be produced in large amounts, and has hst-2 activity, so that it can be advantageously used as drugs for promoting treatment of burns, wounds, etc., and therapeutic agents for gastrointestinal ulcers. Further, it can be utilized as platelet-increasing agents.
摘要翻译:本发明提供由以下氨基酸序列表示的多肽:其中n为0或1,X代表其片段(n = 0:SEQ ID NO:1,n = 1:SEQ ID NO: NO:2),编码该多肽的重组DNA,含有该重组DNA的载体,携带该载体的转化体的制备以及与转化体的多肽的产生。 本发明还提供使用具有肝素结合分泌转化因子2(hst-2)活性的多肽促进哺乳动物血小板数量增加的方法。 该多肽可以大量生产,并具有hst-2活性,因此可有利地用作促进烧伤,伤口等治疗药物和胃肠溃疡治疗剂的药物。 此外,它可以用作血小板递增剂。
摘要:
An antibody which binds to a polypeptide encoded by human PERP (p53 apoptosis effector related to PMP-22) gene which is considered to be related to incidence of cancer or the like is desired. The present invention provides a gene recombinant antibody which has no consensus sequence of an N-linked sugar chain in a variable region, specifically recognizes three-dimensional structure of an extracellular region of a polypeptide encoded by the PERP gene and binds to the extracellular region. The antibody is useful for treatment of various diseases expressing a polypeptide encoded by the PERP gene.
摘要:
The present invention relates to a method for assessing a cancerous state of a mammal-derived specimen, which comprises:
(1) a first step of measuring a methylation frequency of Neurofilament3 gene contained in a mammal-derived specimen or an index value having the correlation therewith, and (2) a second step of determining a cancerous state of the specimen based on a difference obtained by comparing the measured methylation frequency or the index value having the correlation therewith, with a control; and the like.
摘要:
The present invention relates to a method for assessing a cancerous state of a mammal-derived specimen, which comprises:
(1) a first step of measuring a methylation frequency of Fibrillin2 gene contained in a mammal-derived specimen or an index value having the correlation therewith, and (2) a second ,step of determining a cancerous state of the specimen based on a difference obtained by comparing the measured methylation frequency or the index value having the correlation therewith, with a control; and the like.